You can buy Luciavap at the lowest price in the online pharmacy Nextgen.ooo . Avapritinib, or BLU-285,1 is a selective tyrosine kinase inhibitor of KIT and platelet derived growth factor receptor alpha indicated for the treatment of unresectable, metastatic gastrointestinal stromal tumors and advanced systemic mastocytosis. It is one of the first medications available for the treatment of multidrug resistant cancers. Avapritinib shares a similar mechanism with ripretinib. Avapritinib was granted FDA approval on 9 January 2020 4 and EMA approval on 24 September 2020. Avapritinib is indicated for the treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.
 
It is also used to treat adult patients with advanced systemic mastocytosis. Advanced systemic mastocytosis includes patients with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematological neoplasm, and mast cell leukemia. However, it is not recommended for the treatment of patients with advanced systemic mastocytosis with platelet counts of less than 50 X 109 L.